Effects of IL-12 gene therapy on spontaneous transgenic and transplanted breast tumors

Breast Cancer Research and Treatment

Volumn 110, Issue 2, 2008, Pages 223-226

  Faggioli, Francesca ^a,b   Soldati, Sabina ^a,c   Scanziani, Eugenio ^c   Catò, Enrica Mira ^a,b   Adorni, Fulvio ^a,b   Vezzoni, Paolo ^a,b   Noonan, Douglas M ^d   Sacco, Maria Grazia ^a,e  

^a CNR   (Italy)

^b HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d UNIVERSITY OF INSUBRIA   (Italy)

^e JOINT RESEARCH CENTRE   (Italy)

Author keywords

Gene therapy; IL 12; MMTVneu; Transgenic mice; Transplanted breast tumors

Indexed keywords

INTERLEUKIN 12; NAKED DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST TUMOR; CANCER INHIBITION; CANCER MODEL; CANCER TRANSPLANTATION; CONTROLLED STUDY; DNA VECTOR; EXPRESSION VECTOR; GENE THERAPY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BREAST NEOPLASMS; CYTOKINES; DNA; FEMALE; GENE THERAPY; HUMANS; INTERLEUKIN-12; MAMMARY NEOPLASMS, ANIMAL; MAMMARY TUMOR VIRUS, MOUSE; MICE; MICE, NUDE; MICE, TRANSGENIC; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION;

EID: 44849142071     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-007-9713-6     Document Type: Article

References (12)

1. Wolf SF, Temple PA, Kobayashi M et al (1991) Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J Immunol 146:3074-3081
2. Cifaldi L, Quaglino E, Di Carlo E et al (2001) A light, nontoxic interleukin 12 protocol inhibits HER-2/neu mammary carcinogenesis in BALB/c transgenic mice with established hyperplasia. Cancer Res 61:2809-2812
3. Morini M, Albini A, Lorusso G et al (2004) Prevention of angiogenesis by naked DNA IL-12 gene transfer: angioprevention by immunogene therapy. Gene Ther 11:284-291
4. Shibata MA, Ito Y, Morimoto J, Kusakabe K, Yoshinaka R, Otsuki Y (2006) In vivo electrogene transfer of interleukin-12 inhibits tumor growth and lymph node and lung metastases in mouse mammary carcinomas. J Gene Med 8:335-352
5. Sacco MG, Caniatti M, Mira Catò E et al (2000) Liposome-delivered angiostatin strongly inhibits tumor growth and metastatization in a transgenic model of breast cancer. Cancer Res 60:2660-2665
6. Sacco MG, Faggioli F, Soldati S et al (2006) Establishment and characterization of new mammary adenocarcinoma cell lines derived from double transgenic mice expressing GFP and neu oncogene. Cell Prolif 39:611-622
7. Sacco MG, Soldati S, Indraccolo S, Mira Catò E, Cattaneo L, Scanziani E, Vezzoni P (2003) Combined antiestrogen, antiangiogenic and anti-invasion therapy inhibits primary and metastatic tumor growth in the MMTVneu model of breast cancer. Gene Ther 10:1903-1909
8. Cardiff RD, Anver MR, Gusterson BA et al (2000) The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting. Oncogene 19:968-988
9. Lee JC, Kim DC, Gee MS, Saunders HM, Sehgal CM, Feldman MD, Ross SR, Lee WM (2002) Interleukin-12 inhibits angiogenesis and growth of transplanted but not in situ mouse mammary tumor virus-induced mammary carcinomas. Cancer Res 62:747-755
10. Chaouat G, Ledee-Bataille N, Chea KB, Dubanchet S (2005) Cytokines and implantation. Chem Immunol Allergy 88:34-63
11. Hanna J, Goldman-Wohl D, Hamani Y, Avraham I, Greenfield C, Natanson-Yaron S, Prus D, Cohen-Daniel L, Arnon TI, Manaster I, Gazit R, Yutkin V, Benharroch D, Porgador A, Keshet E, Yagel S, Mandelboim O (2006) Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat Med 12:1065-1074
12. Schultz J, Pavlovic J, Strack B, Nawrath M, Moelling K (1999) ong-lasting anti-metastatic efficiency of interleukin 12-encoding plasmid DNA. Hum Gene Ther 10:407-417